VB-0220

Anlage 3 Liste der Suchtmittel, geordnet nach Positionen der Kombinierten Nomenklatur Hinweis: In der Spalte "Anlage" bedeuten: Aes handelt sich um ein in den Anhängen I bis V der Suchtgiftverordnung (siehe Anlage 1) genanntes Suchtgift; der jeweilige Anhang der Suchtgiftverordnung wird durch den Zusatz "(Anhang I)", "(Anhang II)", "(Anhang III)", "(Anhang IV)" oder "(Anhang V)" angegeben; Bes handelt sich um einen in der Anlage 1 der Psychotropenverordnung (siehe Anlage 2) genannten Stoff. Warenkatalog: | KN-Code | Warenbezeichnung | Abschnitt | ex | 0602 90 50 | Hanfpflanzen | A (Anhang I) und Abschnitt 1.1.4. | ex | 0604 20 90 | Mohnstroh (Mohnkapseln) | Abschnitt 1.1.3. | | | Hanfpflanzen | A (Anhang I) und Abschnitt 1.1.4. | | 0604 90 91 0604 90 99 | Mohnstroh (Mohnkapseln) | Abschnitt 1.1.3. | | | Hanfpflanzen | A (Anhang I) und Abschnitt 1.1.4. | | 1211 30 | Cocablätter | A (Anhang I) | ex | 1211 90 86 | Cannabis | A (Anhang I) | ex | 1301 90 | Cannabisharz (Haschisch) | A (Anhang I) | | 1302 11 | Opium, Rohopium | A (Anhang I) | ex | 1302 19 70 | Cannabis-Extrakte und -Tinkturen | A (Anhang I) | | | Mohnstrohkonzentrat | A (Anhang I) | ex | 1404 90 | Mohnstroh (Mohnkapseln) | Abschnitt 1.1.3. | ex | 2905 51 | Ethchlorvynol | B (Anlage 2) | ex | 2918 19 98 | GHB (Gamma-Hydroxybutyrat-Acid) | A (Anhang IV) | | 2921 46 | Amfetamin | A (Anhang IV) | | | Benzfetamin | B (Anlage 2) | | | Dexamphetamin | A (Anhang IV) | | | Etilamfetamin | B (Anlage 2) | | | Fencamfamin | B (Anlage 2) | | | Lefetamin | B (Anlage 2) | | | Levamfetamin | A (Anhang IV) | | | Mefenorex | B (Anlage 2) | | | Phentermin | B (Anlage 2) | ex | 2921 49 | 4-Fluoroamphetamin, 4-FA | A (Anhang IV) | | | 4-Methylamphetamin | A (Anhang V) | | | Eticyclidin | A (Anhang V) | | | PCE | A (Anhang V) | | 2922 14 | Dextropropoxyphen | A (Anhang II) | ex | 2922 19 | Acetylmethadol | A (Anhang I) | | | Alphacetylmethadol | A (Anhang I) | | | Alphamethadol | A (Anhang I) | | | Betacetylmethadol | A (Anhang I) | | | Betamethadol | A (Anhang I) | | | Dimenoxadol | A (Anhang I) | | | Dimepheptanol | A (Anhang I) | | | Levacetylmethadol | A (Anhang I) | | | Noracymethadol | A (Anhang I) | ex | 2922 29 | 25B-NBOMe, 2C-B-NBOMe | A (Anhang V) | | | 25C-NBOMe, 2C-C-NBOMe | A (Anhang V) | | | 25I-NBOMe, 2C-I-NBOMe | A (Anhang V) | | | Brolamfetamin | A (Anhang V) | | | DOB | A (Anhang V) | | | DOC (= 2,5-Dimethoxy-4-chloroamphetamine) | A (Anhang V) | | | DOET | A (Anhang V) | | | DOM | A (Anhang V) | | | STP | A (Anhang V) | | | DMA | A (Anhang V) | | | PMA | A (Anhang V) | | | Tepentadol | A (Anhang I) | | | TMA | A (Anhang V) | | | TMA-2 (2,3,4-Trimethoxyamphetamin) | A (Anhang V) | | | 2C-I (4-Iod-2,5-dimethoxyphenylethylamin) | A (Anhang V) | | 2922 31 | Amfepramon | B (Anlage 2) | | | Methadon, einschließlich Isomethadon und Levo-(R(-)) Methadon (Polamidon) | A (Anhang I) | | | Normethadon | A (Anhang I) | ex | 2922 39 | 3-Chlor-Methcathinon, 3-CMC | A (Anhang V) | 3-Methyl-Methcathinon, 3-MMC | A (Anhang V) | ex | 2922 39 | N-Ethylhexedron | A (Anhang IV) | | 2922 44 | Tilidin | A (Anhang I) | ex | 2922 50 | Methoxetamin, MXE | A (Anhang IV) | | | Tramadol | A (Anhang IV) | | 2924 11 | Meprobamat | B (Anlage 2) | ex | 2924 24 | Ethinamat | B (Anlage 2) | ex | 2924 29 70 | AH-7921 | A (Anhang I) | | | Diampromid | A (Anhang I) | | | U-47700 | A (Anhang I) | | 2925 12 | Glutethimid | B (Anlage 2) | | 2926 30 | Methadon-Zwischenprodukt | A (Anhang I) | | | Fenproporex | B (Anlage 2) | ex | 2930 90 98 | 4-MTA | A (Anhang V) | | 2932 95 | Tetrahydrocannabinole (=THCA) und die im Anhang V angeführten Isomere | A (Anhang V) | ex | 2932 99 | Delta-9-Tetrahydrocannabinol synthetischen Ursprungs und deren stereochemischen Varianten | A (Anhang IV) | | | Ethylon | A (Anhang IV) | Eutylon | A (Anhang IV) | | | Methylon, beta-keto-MDMA | A (Anhang IV) | | | MBDB | A (Anhang V) | | | MDA | A (Anhang V) | | | MDE | A (Anhang V) | | | MDMA | A (Anhang V) | | | N-Äthyl MDA | A (Anhang V) | | | N-Ethylnorpentylon, Ephylon | A (Anhang IV) | | | Tenamfetamin | A (Anhang V) | | | DMHP | A (Anhang V) | | | MMDA | A (Anhang V) | | | N-Hydroxy MDA | A (Anhang V) | | | Parahexyl | A (Anhang V) | ex | 2933 33 | Alfentanil | A (Anhang I) | | | Anileridin | A (Anhang I) | | | Bezitramid | A (Anhang I) | | | Bromazepam | B (Anlage 2) | | | Difenoxin | A (Anhang I) | | | Diphenoxylat | A (Anhang I) | | | Dipipanon | A (Anhang I) | | | Fentanyl | A (Anhang I) | | | Ketobemidon | A (Anhang I) | | | Methylphenidat | A (Anhang IV) | | | Pentazocin | A (Anhang IV) | | | Pethidin | A (Anhang I) | | | Pethidin-Zwischenprodukt A | A (Anhang I) | | | Phencyclidin | A (Anhang IV) | | | Phenoperidin | A (Anhang I) | | | Pipradrol | B (Anlage 2) | | | Piritramid | A (Anhang I) | | | Propiram | A (Anhang II) | | | Trimeperidin | A (Anhang I) | ex | 2933 34 | Brorphin | A (Anhang I) | ex | 2933 39 99 | 4-Fluoroisobutyrfentanyl, 4-FIBF, pFIBF | A (Anhang I) | | | Acetyl-alpha-methylfentanyl | A (Anhang I) | | | Acetylfentanyl | A (Anhang I) | | | Acryloylfentanyl | A (Anhang I) | | | Allylprodin | A (Anhang I) | | | Alpha-methylfentanyl | A (Anhang I) | | | Alphameprodin | A (Anhang I) | | | Alphaprodin | A (Anhang I) | | | Benzethidin | A (Anhang I) | | | Beta-hydroxy-3-methylfentanyl | A (Anhang I) | | | Beta-hydroxyfentanyl | A (Anhang I) | | | Betameprodin | A (Anhang I) | | | Betaprodin | A (Anhang I) | | | Butyrfentanyl | A (Anhang I) | | | Carfentanil | A (Anhang I) | | | Crotonylfentanyl | A (Anhang I) | | | Cyclopropylfentanyl | A (Anhang I) | | | Diphenidin | A (Anhang IV) | | | Ethylphenidat | A (Anhang IV) | | | Etoxeridin | A (Anhang I) | | | Hydroxypethidin | A (Anhang I) | | | Metazocin | A (Anhang I) | | | Methoxyacetylfentanyl | A (Anhang I) | | | 3-MeO-PCP | A (Anhang IV) | | | 3-Methylfentanyl | A (Anhang I) | | | MPPP | A (Anhang I) | | | Norpipanon | A (Anhang I) | | | Ocfentanil | A (Anhang I) | | | Orthoflourofentanyl | A (Anhang I) | | | Parafluorobutyrylfentanyl | A (Anhang I) | | | Para-fluorofentanyl | A (Anhang I) | | | PEPAP | A (Anhang I) | | | Pethidin-Zwischenprodukt B | A (Anhang I) | | | Pethidin-Zwischenprodukt C | A (Anhang I) | | | Phenampromid | A (Anhang I) | | | Phenazocin | A (Anhang I) | | | Piminodin | A (Anhang I) | | | Properidin | A (Anhang I) | | | Remifentanil | A (Anhang I) | | | Valerylfentanyl | A (Anhang I) | | 2933 41 | Levorphanol | A (Anhang I) | ex | 2933 49 90 | 5F-PB-22 | A (Anhang IV) | | | Drotebanol | A (Anhang I) | | | Levomethorphan, ausgenommen Dextromethorphan | A (Anhang I) | | | Levophenacylmorphan | A (Anhang I) | | | Norlevorphanol | A (Anhang I) | | | Phenomorphan | A (Anhang I) | | | Racemethorphan | A (Anhang I) | | | Racemorphan | A (Anhang I) | | 2933 53 | Amobarbital | B (Anlage 2) | | | Barbital | B (Anlage 2) | | | Phenobarbital | B (Anlage 2) | | | Allobarbital | B (Anlage 2) | | | Butalbital | B (Anlage 2) | | | Butobarbital | B (Anlage 2) | | | Cyclobarbital | B (Anlage 2) | | | Methylphenobarbital | B (Anlage 2) | | | Pentobarbital | B (Anlage 2) | | | Secbutabarbital | B (Anlage 2) | | | Secobarbital | A (Anhang IV) | | | Vinylbital | B (Anlage 2) | | 2933 55 | Loprazolam | B (Anlage 2) | | | Mecloqualon | A (Anhang IV) | | | Methaqualon | A (Anhang IV) | | | Zipeprol | A (Anhang IV) | ex | 2933 59 95 | Benzylpiperazin (BZP) | A (Anhang V) | | | MT-45 | A (Anhang I) | | 2933 72 | Clobazam | B (Anlage 2) | | | Methyprylon | B (Anlage 2) | ex | 2933 91 10 | Flualprazolam | B (Anlage 2) | ex | 2933 91 90 | Alprazolam | B (Anlage 2) | | | α-Pyrrolidinovalerophenon, α-PVP | A (Anhang IV) | | | Camazepam | B (Anlage 2) | | | Clonazepam | B (Anlage 2) | | | Diazepam | B (Anlage 2) | | | Estazolam | B (Anlage 2) | | | Ethylloflazepate | B (Anlage 2) | | | Fludiazepam | B (Anlage 2) | | | Flunitrazepam | B (Anlage 2) | | | Flurazepam | B (Anlage 2) | | | Halazepam | B (Anlage 2) | | | Lorazepam | B (Anlage 2) | | | Lormetazepam | B (Anlage 2) | | | Medazepam | B (Anlage 2) | | | Midazolam | B (Anlage 2) | | | Nimetazepam | B (Anlage 2) | | | Nitrazepam | B (Anlage 2) | | | Nordazepam | B (Anlage 2) | | | Oxazepam | B (Anlage 2) | | | Pinazepam | B (Anlage 2) | | | Prazepam | B (Anlage 2) | | | Temazepam | B (Anlage 2) | | | Tetrazepam | B (Anlage 2) | | | Triazolam | B (Anlage 2) | | | Chlordiazepoxid | B (Anlage 2) | | | Clorazepat | B (Anlage 2) | | | Delorazepam | B (Anlage 2) | | | Mazindol | B (Anlage 2) | | | Pyrovaleron | B (Anlage 2) | ex | 2933 99 80 | 4F-MDMB-BICA | A (Anhang V) | | | 4F-MDMB-BINACA | A (Anhang IV) | | | 5-(2-Aminopropyl)indol | A (Anhang V) | | | 5F-AMB-PINACA, 5F-AMB, 5F-MMB-PINACA | A (Anhang IV) | | | 5F-APINACA, 5F-AKB-48 | A (Anhang IV) | | | 5F-MDMB-PICA, 5F-MDMB-2201 | A (Anhang IV) | | | 5F-MDMB-PINACA, 5F-ADB | A (Anhang IV) | | | α-PHP | A (Anhang IV) | | | AB-CHMINACA | A (Anhang IV) | | | AB-FUBINACA | A (Anhang IV) | | | AB-PINACA | A (Anhang IV) | | | ADB-CHMINACA | A (Anhang V) | | | AMB-FUBINACA | A (Anhang IV) | | | AM-2201 | A (Anhang IV) | | | Clonazolam | B (Anlage 2) | | | Clonitazen | A (Anhang I) | | | CUMYL-4CN-BINACA | A (Anhang V) | | | CUMYL-PeGACLONE | A (Anhang IV) | | | Diclazepam | B (Anlage 2) | | | Etonitazen | A (Anhang I) | | | Etryptamin | A (Anhang V) | | | Flubromazolam | B (Anlage 2) | | | FUB-AMB, MMB-FUBINACA, AMB-FUBINACA | A (Anhang IV) | | | Isotonitazen | A (Anhang I) | | | JWH-018 | A (Anhang IV) | | | MDMB-4en-PINACA | A (Anhang IV) | | | MDMB-CHMICA | A (Anhang IV) | Metonitazen | A (Anhang I) | | | PCPY | A (Anhang V) | | | Phenazepam | B (Anlage 2) | | | PHP | A (Anhang V) | | | Proheptazin | A (Anhang I) | | | Rolicyclidin | A (Anhang V) | | | UR-144 | A (Anhang IV) | | | XLR-11 | A (Anhang IV) | | | Zolpidem | B (Anlage 2) | | 2934 91 | Aminorex | B (Anlage 2) | | | Brotizolam | B (Anlage 2) | | | Clotiazepam | B (Anlage 2) | | | Cloxazolam | B (Anlage 2) | | | Dextromoramid | A (Anhang I) | | | Haloxazolam | B (Anlage 2) | | | Ketazolam | B (Anlage 2) | | | Mesocarb | B (Anlage 2) | | | Oxazolam | B (Anlage 2) | | | Pemolin | B (Anlage 2) | | | Phendimetrazin | B (Anlage 2) | | | Phenmetrazin | A (Anhang IV) | | | Sufentanil | A (Anhang I) | | 2934 99 90 | Alpha-methylthiofentanyl | A (Anhang I) | | | 3,4-Methylendioxypyrovaleron, MDPV | A (Anhang IV) | | | 3-Methylthiofentanyl | A (Anhang I) | | | Diethylthiambuten | A (Anhang I) | | | Dimethylthiambuten | A (Anhang I) | | | Dioxaphetylbutyrat | A (Anhang I) | | | Ethylmethylthiambuten | A (Anhang I) | | | Etizolam | B (Anlage 2) | | | Furanylfentanyl | A (Anhang I) | | | Furethidin | A (Anhang I) | | | Levomoramid | A (Anhang I) | | | Methiopropamin, MPA | A (Anhang IV) | | | 4-Methylaminorex | A (Anhang V) | | | Moramid-Zwischenprodukt | A (Anhang I) | | | Morpheridin | A (Anhang I) | | | Paramethyl-4-methylaminorex, 4,4'-DMAR | A (Anhang IV) | | | Phenadoxon | A (Anhang I) | | | Racemoramid | A (Anhang I) | | | Tenocyclidin (=TCP) | A (Anhang V) | | | Tetrahydrofuranylfentanyl, THF-F | A (Anhang I) | | | 2-C-T-2 (2,5-Dimethoxy-4-ethylthiophenylethylamin) | A (Anhang V) | | | 2-C-T-7 (2,5-Dimethoxy-4(n)-propylthiophenylethylamin) | A (Anhang V) | | 2939 11 | Buprenorphin | A (Anhang IV) | | | Codein | A (Anhang II) | | | Diacetylmorphin (Heroin) | A (Anhang I) | | | Dihydrocodein | A (Anhang II) | | | Ethylmorphin (Äthylmorphin) | A (Anhang II) | | | Etorphin | A (Anhang I) | | | Heroin, Diacetylmorphin | A (Anhang I) | | | Hydrocodon | A (Anhang I) | | | Hydromorphon | A (Anhang I) | | | Mohnstrohkonzentrat | A (Anhang I) | | | Morphin | A (Anhang I) | | | Nicomorphin | A (Anhang I) | | | Oxycodon | A (Anhang I) | | | Oxymorphon | A (Anhang I) | | | Pholcodin | A (Anhang II) | | | Thebacon | A (Anhang I) | | | Thebain | A (Anhang I) | ex | 2939 19 | Acetorphin | A (Anhang I) | | | Acetyldihydrocodein | A (Anhang II | | | Benzylmorphin | A (Anhang I) | | | Codein-N-oxid | A (Anhang I) | | | Codoxim | A (Anhang I) | | | Desomorphin | A (Anhang I) | | | Dihydromorphin | A (Anhang I) | | | Hydromorphinol | A (Anhang I) | | | Methyldesorphin | A (Anhang I) | | | Methyldihydromorphin | A (Anhang I) | | | Metopon | A (Anhang I) | | | Monoacetylmorphin, 6-Acetyl-Morphin | A (Anhang I) | | | Morphinmethobromid und andere quartäre Salze des Morphins | A (Anhang I) | | | Morphin-N-oxid | A (Anhang I) | | | Myrophin | A (Anhang I) | | | Nicocodin | A (Anhang II | | | Nicodicodin | A (Anhang II | | | Norcodein | A (Anhang II | | | Normorphin | A (Anhang I) | | | Oripavin | A (Anhang I) | | 2939 43 | Cathin | B (Anlage 2) | ex | 2939 44 | (+)-Norpseudoephedrin | B (Anlage 2) | | 2939 51 | Fenetyllin | A (Anhang IV) | ex | 2939 69 | LSD, LSD-25, (+)-Lysergid | A (Anhang V) | ex | 2939 7172 | Levomethamphetamin | A (Anhang IV) | | | Cocain | A (Anhang I) | | | Ecgonin | A (Anhang I) | | | Metamphetamin-Razemat | A (Anhang IV) | | | Methamphetamin | A (Anhang IV) | | | PMMA (Anhang Anhang Paramethoxymethamphetamin) | A (Anhang V) | ex ex | 2939 79 2939 80 | 2C-B (4-Bromo-2,5 dimethoxyphenethylamin) | A (Anhang V) | | | 4-CMC, 4-Chloromethcathinon, Clephedron | A (Anhang IV) | | | Cathinon | A (Anhang V) | | | DET | A (Anhang V) | | | DMT | A (Anhang V) | | | Mescalin | A (Anhang V) | | | Methcathinon | A (Anhang V) | | | 4-Methylethcathinon, 4-MEC | A (Anhang IV) | | | 4-Methyl-Methcathinon ("Mephedron") | A (Anhang V) | | | Pentedron | A (Anhang IV) | | | Psilocin, Psilotin | A (Anhang V) | | | Psilocybin | A (Anhang V) | | | Thiofentanyl | A (Anhang I) | ex | 3001 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2) | ex | 3002 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2) | ex | 3003 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2) | ex | 3004 | Waren dieser Position, sofern sie Suchtmittel enthalten | A (Anlage 1, Anhang I - V), B (Anlage 2)